El etanercept y efalizumab para el tratamiento de la psoriasis: una revisión sistemática

Categoría Resumen estructurado de revisiones sistemáticas
RevistaDatabase of Abstracts of Reviews of Effects (DARE)
Año 2007
Cargando información sobre las referencias

CRD SUMMARY:

This 2006 review found that etanercept and efalizumab were efficacious for patients with moderate-to-severe chronic plaque psoriasis, but they were only likely to be cost-effective for patients with a poor quality of life before treatment, who were at risk of hospitalisation. Long-term trials and trials comparing the drugs were needed. The mixed-treatment comparison favoured etanercept.
Epistemonikos ID: abb233edc56ea86f3eacaecfc1ab4a2a7b7659b4
First added on: Jun 07, 2012